Proteomics and weighted gene correlated network analysis reveal glutamatergic synapse signaling in diazepam treatment of alcohol withdrawal
Background: Alcohol use disorder (AUD) is characterized by chronic excessive alcohol consumption, often alternating with periods of abstinence known as alcohol withdrawal syndrome (AWS). Diazepam is the preferred benzodiazepine for treatment of alcohol withdrawal syndrome under most circumstances, b...
Main Authors: | Wan Kong, Shanqing Huang, Zikai Chen, Xiaolin Li, Shujing Liu, Zi Zhang, Ye Yang, Zhanzhang Wang, Xiuqing Zhu, Xiaojia Ni, Haoyang Lu, Ming Zhang, Zezhi Li, Yuguan Wen, Dewei Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1111758/full |
Similar Items
-
The neurobehavioral and withdrawal effects of diazepam in adult male rats
by: Mohammed Jawad kadhim, et al.
Published: (2014-12-01) -
Combination of dexmedetomidine and diazepam in treatment of a patient with severe alcohol withdrawal syndrome complicated with fever
by: Li Yanling, Fu Yongmei
Published: (2023-03-01) -
Pregabalin abuse and dependence during insomnia and protocol for short-term withdrawal management with diazepam: examples from case reports
by: Basavaraja Papanna, et al. -
The Effects of Doxapram Blocking the Response of Gram-Negative Bacterial Toxin (LPS) at Glutamatergic Synapses
by: Kaitlyn E. Brock, et al.
Published: (2023-07-01) -
Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
by: Rosa M Villalba, et al.
Published: (2015-09-01)